By Davit Kirakosyan Investing.com -- Here is your daily Pro Recap of the analysts' biggest positive rating moves you may have missed on InvestingPro. Start your free 7-day trial to get this...
Singapore, Feb. 20, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the Global Ataxia Diagnosis and Treatment Market is expected to clock US$...
Investing.com - Bluebird reported on Monday third quarter {{erl-40978||earnings that beat analysts' forecasts and revenue that fell short of expectations. Bluebird announced earnings per...
Pre-Open Stock Movers:Virios Therapeutics, Inc. (Nasdaq: VIRI) 63% LOWER; announced topline results from its FORTRESS (Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression...
By Senad Karaahmetovic Shares of Bluebird Bio (NASDAQ:BLUE) are up about 10% today after the United States Food and Drug Administration (FDA) yesterday cleared the company’s Zynteglo...
Pre-Open Stock Movers:Wolfspeed (WOLF) 21% HIGHER; reported Q4 EPS of ($0.02), $0.08 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $228.5 million versus the...
By Sam Boughedda bluebird bio's (NASDAQ:BLUE) cell-based gene therapy, Zynteglo, has been approved for the treatment of adult and pediatric patients with beta-thalassemia by the U.S. Food...
By Vlad Schepkov Shares of bluebird bio, Inc. (NASDAQ:BLUE) are peeking above $6, up as much as 80% in heavy trading on Monday morning, after the FDA AdCom voted unanimously in favor of...
Pre-Open Stock Movers:bluebird bio, Inc. (Nasdaq: BLUE) 60% HIGHER; an FDA AdCom voted 13 (yes) to 0 (no) that the benefits of beti-cel outweigh the risks for the treatment of subjects with...
By Dhirendra Tripathi Investing.com – Shares of Bluebird (NASDAQ:BLUE) jumped 7% Monday on news that a therapy the company has developed with Bristol-Myers (NYSE:BMY) to treat adults...
Investing.com – U.S. equities were mixed at the close on Tuesday, as gains in the Oil & Gas, Financials and Basic Materials sectors propelled shares higher while losses in the Healthcare,...
(Adds Monte dei Paschi di Siena, Frontier Pharma, Marks & Spencer; updates Staples)Jan 11 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on...
(Corrects to clarify in second graph that patients will be infused by a healthcare provider)By John Miller and Carl O'DonnellNov 15 (Reuters) - Novartis AG NOVN.S on Friday won U.S....
(Updates to close, adds commentary) * Energy, technology sectors provide biggest boosts * Health investors look to conference presentations * Bluebird Bio-Celgene CAR-T drug receives...
(Corrects paragraph four to reflect that 85 pct of traders expect a 25 basis point rate hike) * Energy, technology sectors provide biggest boosts * Health investors look to conference...
* Apple confirms acquisition of Shazam Entertainment * Bluebird Bio-Celgene CAR-T drug receives positive response * Cryptocurrency related stocks bounce after bitcoin futures debut *...
* Bluebird Bio-Celgene CAR-T drug receives positive response * Cryptocurrency related stocks bounce after bitcoin futures debut * Xerox up after Icahn nominates four directors * Indexes...
* Bluebird Bio-Celgene CAR-T drug receives positive response * Cryptocurrency related stocks bounce after bitcoin futures debut * Xerox up after Icahn nominates four directors * Indexes...
* Bluebird Bio-Celgene CAR-T drug receives positive response * Cryptocurrency related stocks bounce after bitcoin futures debut * Futures up: Dow 41 pts, S&P 1.75 pts, Nasdaq 7.5 pts...
* Futures up: Dow 46 pts, S&P 2.25 pts, Nasdaq 7.25 pts By Sruthi Shankar Dec 11 (Reuters) - U.S. stock futures pointed to a higher opening for Wall Street on Monday, with the launch...
* Futures up: Dow 0.09 pts, S&P 0.05 pts, Nasdaq 0.04 pts By Yashaswini Swamynathan Dec 7 (Reuters) - U.S. stock index futures rose for the third straight day, as investors continued...
* Nasdaq trading close to two-week low, weighed down by Facebook * Technology index set for worst day since August * Brent rises over 5 pct; Exxon (NYSE:XOM) and Chevron (NYSE:CVX) lead...
* Nasdaq trading at two-week low, weighed down by Facebook * Technology index set for worst day since August * Oil prices rise more than 4 pct; Exxon (NYSE:XOM) and Chevron (NYSE:CVX)...
* Oil builds on Wednesday's rally, up nearly 3 pct * Facebook top drag on S&P, Nasdaq * Guess, Express Inc plunge on cut in profit forecasts * Dow up 0.19 pct, S&P up 0.03 pct,...
* Oil builds on Wednesday's rally, up nearly 2 pct * Jobless claims up more than expected last week - report * Guess, Express Inc plunge on cut in profit forecasts * Futures: Dow up 4...
* Futures down: Dow 11 pts, S&P 3.5 pts, Nasdaq 10 pts By Yashaswini Swamynathan Dec 1 (Reuters) - U.S. stock index futures kicked off December on a somber note ahead of a raft of data...
* August retail sales drop more-than-expected * Weekly jobless claims rise to 260,000 vs est. 265,000 * Apple rises on strong iPhone 7 Plus sales * Futures up: Dow 36 pts, S&P 3.5...
* Futures up: Dow 60 pts, S&P 6.75 pts, Nasdaq 15.5 pts By Yashaswini Swamynathan Sept 15 (Reuters) - U.S. stock index futures were higher on Thursday ahead of a raft of economic data,...
* McDonald's down after revealing turnaround plan* AMC, Cognizant hit record high after results* U.S. factory orders post largest gain in eight months* Indexes up: Dow 0.4 pct, S&P...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
